The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1Z,5E,8S,9S)-10-Oxabicyclo[7.2.1]dodeca-5,12-dien-11-one, 4-(((furan-2-carbonyl)oxy)imino)-5-methyl-8-(1-methylethenyl)- ID: ALA4465221
PubChem CID: 155531018
Max Phase: Preclinical
Molecular Formula: C20H21NO5
Molecular Weight: 355.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=C(C)[C@@H]1C/C=C(C)/C(=N\OC(=O)c2ccco2)CCC2=C[C@@H]1OC2=O
Standard InChI: InChI=1S/C20H21NO5/c1-12(2)15-8-6-13(3)16(9-7-14-11-18(15)25-19(14)22)21-26-20(23)17-5-4-10-24-17/h4-6,10-11,15,18H,1,7-9H2,2-3H3/b13-6+,21-16-/t15-,18-/m0/s1
Standard InChI Key: LVSWCOIEJHPOAM-TURNLRKXSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
35.5131 -8.6543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5202 -9.2717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6736 -8.4030 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
32.7559 -7.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8070 -7.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4180 -7.3356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2323 -7.4237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6707 -6.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5161 -7.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9619 -6.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0084 -8.6069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0973 -6.1747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9619 -7.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3839 -6.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8124 -6.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8317 -8.6069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0907 -7.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6696 -5.3421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9656 -7.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3836 -4.9285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3825 -4.1035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0965 -3.6900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6673 -3.6919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8541 -4.0236 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4054 -3.4097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9919 -2.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1851 -2.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 2 2 0
17 6 1 0
17 3 1 6
14 12 2 0
4 11 1 0
9 7 1 0
16 17 1 0
5 9 1 1
17 5 1 0
10 13 1 0
6 4 2 0
9 1 2 0
14 8 1 0
15 12 1 0
13 4 1 0
11 16 1 0
10 8 1 0
5 15 1 0
8 18 2 0
14 19 1 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 22 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.39Molecular Weight (Monoisotopic): 355.1420AlogP: 3.97#Rotatable Bonds: 3Polar Surface Area: 78.10Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.61CX Basic pKa: 1.50CX LogP: 4.42CX LogD: 4.42Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.35Np Likeness Score: 1.16
References 1. Lou LL, Ni FQ, Chen L, Shaker S, Li W, Wang R, Tang GH, Yin S.. (2019) Germacrane Sesquiterpenoids as a New Type of Anticardiac Fibrosis Agent Targeting Transforming Growth Factor β Type I Receptor., 62 (17): [PMID:31408333 ] [10.1021/acs.jmedchem.9b00708 ]